Bictegravir Intermediate Purification via Salt Formation

The patent applies preliminary action by performing purification at intermediate stages during the multi-step synthesis process, rather than attempting to remove impurities at the final stage. Specifically, purification steps are inserted after forming compounds of Formula I and Formula II to remove open chain and diastereomer impurities before they carry forward to contaminate the final bictegravir product. This early intervention prevents impurity propagation and simplifies the overall purification burden.

The patent employs extraction principles by selectively removing harmful impurities (open chain and diastereomer compounds) from the reaction mixture at intermediate stages. The purification processes described involve separating and eliminating these specific impurity types from compounds of Formula I and Formula II, effectively extracting the harmful components before they can affect the final product quality.

By performing purification at intermediate stages rather than at the final stage, the patent achieves better overall yield. The purification steps are strategically placed after forming compounds of Formula I and Formula II, removing impurities before they propagate through subsequent synthesis steps. This approach prevents the compounding of losses that would occur if multiple purification steps were performed sequentially on the final product.

The patent converts the potential harm of multiple purification steps into a benefit by optimizing the timing and sequence of purification operations. Rather than viewing each purification step as a source of yield loss, the process design integrates purification at stages where it prevents greater losses downstream, effectively transforming the necessity of multiple purifications into a strategy for maximizing overall yield while maintaining high purity.